BRX 0.25 (Rexulti 0.25 mg)

Generic Name: brexpiprazole

Pill imprint BRX 0.25 has been identified as Rexulti 0.25 mg.

Rexulti is used in the treatment of major depressive disorder; schizophrenia; depression and belongs to the drug class atypical antipsychotics. Rexulti 0.25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Rexulti

Generic Name:

brexpiprazole

Imprint:

BRX 0.25

Strength:

0.25 mg

Color:

Brown

Shape:

Round

Availability:

Prescription only

Drug Class:

Atypical antipsychotics

CSA Schedule:

Not a controlled drug

Manufacturer:

Otsuka Pharmaceutical Co., Ltd. and Lundbeck

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.